Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized JH509 for hospitalized adults with mild to moderate COVID-19
jRCT2051200159Recruiting
- Sponsor
- Genova
- Start
- Mar 2021
- Countries
- 1
01
Overview
Randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing JH509 with Placebo (2 arms). Primary endpoint: Time to clinical improvement by two points on a 7-point ordinal scale. Started Mar 2021; status: recruiting.
02
Drugs
JH509
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT2051200159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051200159.